Showing results (1281-1290 of 1,364) with videos related to
Sort By:
Pageof 137
Frontiers in Oncology|June 21, 2024
Treatment experience for different risk groups of Kaposiform hemangioendotheliomaMiaomiao Li, Xusheng Wang, Rosalind Kieran, et al.Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|October 28, 2006
[Surgical treatment of hepatocellular carcinoma with tumor thrombus in inferior vena cava]Shu-you Peng, Xiu-jun Cai, Yi-ping Mu, et al.Carcinogenesis|August 7, 2013
Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cellsJianmin Wu, Xue-Jiao Zhang, Ke-Qing Shi, et al.Aging|September 29, 2020
D-galactose induces senescence of glioblastoma cells through YAP-CDK6 pathwayXingxing Xu, Xiya Shen, Wenjin Feng, et al.Zoological Research|April 22, 2025
Convergent musk biosynthesis across host and microbiota in musk deer and muskratYi-Shan Sun, Lei Zhao, Cheng-Li Zheng, et al.British Journal of Haematology|July 1, 2026
Clinical heterogeneity in congenital factor XII deficiency: Coexisting risk factors in thrombotic and bleeding eventsXinmiao Qu, Yujiao Jia, Yuhua Wang, et al.Biomedical and Environmental Sciences : BES|November 14, 2018
Influence of Familiarity on Energy Intake and Plasma Gut Hormone Concentration in Lean and Overweight Young Male StudentsLei Qi, Yan Bo Qi, Peng Zhao, et al.Clinical and Experimental Medicine|July 7, 2024
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosisAnqi Zhang, Ting Sun, Dandan Yu, et al.Journal of Thrombosis and Haemostasis : JTH|February 16, 2023
Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitorsWei Liu, Feng Xue, Rongfeng Fu, et al.Cell Death & Disease|September 27, 2022
Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLCJuanjuan Xiao, Lu Zhang, Huijun Yi, et al.Pageof 137